Jane Street Group, LLC Arbutus Biopharma Corp Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$2.42 - $3.98 $94,380 - $155,220	-39,000 Reduced 14.73%	225,700 $673,000
Q4 2021 Feb 15, 2022	BUY	$3.11 - $4.61 $243,824 - $361,424	78,400 Added 42.08%	264,700 $1.03 Million
Q3 2021 Nov 16, 2021	BUY	$2.65 - $4.62 $381,335 - $664,818	143,900 Added 339.39%	186,300 $799,000
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.51 $11,250 - $15,794	-4,500 Reduced 9.59%	42,400 $128,000
Q1 2021 May 18, 2021	SELL	$3.14 - $4.84 $109,272 - $168,432	-34,800 Reduced 42.59%	46,900 $156,000

Q4 2020 Feb 17, 2021	BUY	$2.76 - $4.97 $225,491 - $406,049	81,700 New	81,700 $290,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.